guidance|FDA|bench testing|
<br>
Recommended Content and Format of
Non-Clinical Bench Performance
Testing Information in Premarket
Submissions<br>
relevant information on :
<ul>
<li>report summaries</li>
<li>test protocols</li>
<li>complete test reports</li>
</ul>
<br>
non clinical bench performance testing :
<ul>
<li> performance testing</li>
<li>mechanical and biological engineering performance</li>
<li>fatigue</li>
<li>wear</li>
<li>tensile strength</li>
<li>compression</li>
<li>burst pressure</li>
<li>ex vivo</li>
<li>in situ animal</li>
<li>human tissue</li>
<li>animal carcass</li>
<li>human cadaveric testing</li>

</ul>
<br>
excluded from this document
<br>
<ul>
<li>biocompatibility evaluation</li>
<li>reprocessing</li>
<li>sterilization validation</li>
<li>human factors</li>
<li>software verification and validation</li>
<li>computational modeling</li>
<li>
</ul>
<h1>reporting of non clinical bench testing information</h1>
<b>test reportsummaries</b>
a summary of the conducted testing<br>
<b>complete test report</b></br>
<b>test protocol</b><br>
<b>how the bench testing results support the overall submisson on substantial equivalence, reasonable assurance of safety and effectiveness for PMA</b><br>
<h2>test report summaries</h2>
<ul>
<li>briefe test report summaries</li>
<h2>tests performed</h2>
<li>fda recomended guidance from which test was performed</li>
<li>fda recomended standars from which test was performed</li>
<h2>objective of test</h2>
<h2>description of the test method used</h2>
<li>reference to established methods followed</li>
<li>description of test sample</li>
<li> sampe selection- how the samples represented a clinical relvant worst case scenario</li>
<h2>pre defined passs/fail |aceptance criteri-pre defined</h2>
<li> interpretation of data</li>
<h2> results summary</h2>
<li> summary of data in tabular or text format</li>
<li>quantitative assesment</li>
<li>mean|standard deviation|minimum and maximum for normal data|summary parameters|data analysis plan</li>
<li>attribute or qualitative data</li>
<li>summary of observed characteristics</li>
<li>characteristics present|total observations|characteristics absent|confidence stats info|reliability level|
<li> specify wheather acceptance criteria </li>
<li>study results that do not meet acceptance criteria</li>
<li>protocol deviations</li>
<li>conclusions</li>
<li>data integrity</li>
<li>how resulting concerns were resolved</li>
<h2>discussions/conclusions</h2>
<li>discussions of conclusions drawn</li>
<li>additional information on testing done</li>
<li>justification of methods used</li>
<li>clinical/scientific/engineering basis for acceptance criteria;outlying and anomolous results</li>
<li>discussion of acceptance criteria and test methods</li>
<li>how testing relates to use of device</li>
<li>discussion and justification for the mechanisms and processes used</li>
<li>how testing relates to expected worstcase scenarios</li>
<li>non-clinical bench testing done for characterization purposes</li>
<li>relationship between results and intended purpose</li>
<li>brief on how the test results support the overall submission</li>
<h2> location of complete test reports</h2>
<li>link the sectioons, page numbers and document references</li>
<h2>summary table</h2>
</ul>
<h1>complete test reports</h1>
<ul>
<h2>test performed</h2>
<h2>objective of test</h2>
<h2>description of test methods</h2>
<li>such that an individual familiar with testing will be able to interpret the data and purpose of test</li>
<li>information of standard followed and guidance and to what extent it was followed deviations if any</li>
<li>what is to be tested|which method to test|performance limits to asses confirmity|explnations of choices and selections made</li>
<h2>test sample information</h2>
<li>final or finshed device|entire device|

<li>
<li>
</ul>

<h1>
<h1>references to other guidances</h1>
“Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices”<br>
“Standards Development and the Use of Standards in Regulatory Submissions Reviewed in the Center for Biologics Evaluation and Research.”<br>
The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] - Guidance for Industry and Food and Drug Administration Staff”,<br>
De Novo Classification Process (Evaluation of Automatic Class III Designation) - Guidance for Industry and Food and Drug Administration Staff”,<br>
“eCopy Program for Medical Device Submissions - Guidance for Industry and Food and Drug Administration Staff,”<br>
